Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ahmedzai

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|November 1, 1983
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapyS Ahmedzai, D L Carlyle, I T Calder, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of LifeB Bergman, N K Aaronson, S Ahmedzai, et al.
Scandinavian Journal of Thoracic and Cardiovascular Surgery|January 1, 1995
Intracranial metastases from malignant pleural mesotheliomaM J Davies, S Ahmedzai, S S Arsiwala, et al.
Critical Reviews in Oncology/Hematology|December 28, 1999
Costs of palliative care in the community, in hospitals and in hospices in the UKD Coyle, N Small, A Ashworth, et al.
Seminars in Oncology|March 1, 1985
The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer GroupS Banham, A Dorward, A Hutcheon, et al.
Cancer Treatment Reviews|September 1, 1983
Treatment of small cell carcinoma of lung with late dosage intensification programmes containing cyclophosphamide and mesnaS Banham, M Soukop, A Burnett, et al.
Journal of the National Cancer Institute|March 3, 1993
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyN K Aaronson, S Ahmedzai, B Bergman, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1984
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized studyJ A Elliott, S Ahmedzai, D Hole, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lungD Cunningham, S W Banham, A H Hutcheon, et al.
Thorax|September 1, 1986
Short duration combination chemotherapy in the treatment of small cell lung cancerA J Dorward, S W Banham, A W Hutcheon, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|November 1, 1983
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapyS Ahmedzai, D L Carlyle, I T Calder, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of LifeB Bergman, N K Aaronson, S Ahmedzai, et al.
Scandinavian Journal of Thoracic and Cardiovascular Surgery|January 1, 1995
Intracranial metastases from malignant pleural mesotheliomaM J Davies, S Ahmedzai, S S Arsiwala, et al.
Critical Reviews in Oncology/Hematology|December 28, 1999
Costs of palliative care in the community, in hospitals and in hospices in the UKD Coyle, N Small, A Ashworth, et al.
Seminars in Oncology|March 1, 1985
The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer GroupS Banham, A Dorward, A Hutcheon, et al.
Cancer Treatment Reviews|September 1, 1983
Treatment of small cell carcinoma of lung with late dosage intensification programmes containing cyclophosphamide and mesnaS Banham, M Soukop, A Burnett, et al.
Journal of the National Cancer Institute|March 3, 1993
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyN K Aaronson, S Ahmedzai, B Bergman, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1984
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized studyJ A Elliott, S Ahmedzai, D Hole, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lungD Cunningham, S W Banham, A H Hutcheon, et al.
Thorax|September 1, 1986
Short duration combination chemotherapy in the treatment of small cell lung cancerA J Dorward, S W Banham, A W Hutcheon, et al.
Pageof 4